<Suppliers Price>

WIN 54954

Names

[ CAS No. ]:
107355-45-3

[ Name ]:
WIN 54954

[Synonym ]:
5-<5-(2,6-dichloro-5-oxazolylphenoxy)pentyl>-3-methylisoxazole
5-{5-[2,6-Dichloro-4-(4,5-dihydro-oxazol-2-yl)-phenoxy]-pentyl}-3-methyl-isoxazole
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-methylisoxazole
WIN 54954
Win 54954
5-{5-[2,6-Dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxyl]-pentyl}-3-methylisoxazole

Biological Activity

[Description]:

WIN 54954 is a broad-spectrum antipicornavirus agent. WIN 54954 is effectiveness against human rhinovirus, echovirus 9 and enterovirus infections[1][2].

[Related Catalog]:

Research Areas >> Infection

[In Vitro]

WIN 54954 reduces plaque formation of 50 of 52 rhinovirus serotypes (MICs ranges from 0.007 to 2.2 μg/mL)[1].WIN 54954 inhibits 15 commonly isolated enteroviruses, with an EC80 of 0.06 μg/mL[1].

[In Vivo]

WIN 54954 (2-100 mg/kg; p.o.) protects 50% of the mice from developing paralysis following infection with coxsackievirus A-9 and echovirus-9 at the dose of 2 and 100 mg/kg, respectively[1].

[References]

[1]. Woods MG, et, al. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother. 1989 Dec;33(12):2069-74.

[2]. Fechner H, et, al. Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. Molecules. 2011 Oct 11;16(10):8475-503.

Chemical & Physical Properties

[ Molecular Formula ]:
C18H20Cl2N2O3

[ Molecular Weight ]:
383.27

[ Exact Mass ]:
382.08500

[ PSA ]:
56.85000

[ LogP ]:
4.29400

Related Compounds